Disrupted Brain Hierarchical Organization in Alzheimer's Disease Progression

阿尔茨海默病进展过程中大脑层级结构的紊乱

阅读:2

Abstract

Alzheimer's disease (AD) arises from synergistic interactions between amyloid-β, tau, and neurodegeneration, yet it remains unclear how these mechanisms reshape the hierarchical organization of large-scale brain dynamics. Here, we quantified directed causal interactions across 134 participants spanning the AD continuum, comprising 46 amyloid-negative healthy controls (HC-), 36 amyloid-positive healthy controls (HC+), 31 amyloid-positive individuals with mild cognitive impairment (MCI+), and 21 amyloid-positive patients with AD dementia (AD+). Resting-state fMRI was modelled using generative effective connectivity, and hierarchical organization was assessed via trophic levels and directedness. Healthy older adults exhibited a canonical hierarchy in which sensorimotor and frontoparietal regions acted as causal sources, the default mode network (DMN) occupied an intermediate mediating position, and visual-limbic areas functioned as sinks. In contrast, AD+ individuals exhibited elevated trophic levels in the visual network and reduced levels in somatomotor, salience, control, and DMN systems. This shift was accompanied by decreased directedness, indicating a more flattened and less stratified architecture with reduced computational flexibility. MCI+ participants exhibited disruptions in somatomotor and dorsal attention networks. Compared to early-stage HC+, visual and DMN showed similar alterations while the control system returned to baseline before decreasing in AD+. Machine-learning classification distinguished all stages, including subtle differences between HC- and HC+. Hierarchical alterations were shaped by ATN biomarkers and strongly associated with cognitive decline, highlighting trophic metrics as sensitive neuroimaging biomarkers of AD progression. Together, these findings suggest that reduced hierarchical structure represents a core systems-level signature of AD, offering a promising avenue for early detection and therapeutic targeting.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。